Escudero-Sanchez, R.; Morata, L.; Buzón, L.; de la Villa, S.; Rico, A.; Nuñez Orantos, M.J.; Guio Carrion, L.; Tasias Pitarch, M.; del Pozo, J.L.; Barbero, J.M.;
et al. Dalbavancin as Suppressive Therapy for Implant-Associated Osteoarticular Infections. Antibiotics 2025, 14, 1171.
https://doi.org/10.3390/antibiotics14111171
AMA Style
Escudero-Sanchez R, Morata L, Buzón L, de la Villa S, Rico A, Nuñez Orantos MJ, Guio Carrion L, Tasias Pitarch M, del Pozo JL, Barbero JM,
et al. Dalbavancin as Suppressive Therapy for Implant-Associated Osteoarticular Infections. Antibiotics. 2025; 14(11):1171.
https://doi.org/10.3390/antibiotics14111171
Chicago/Turabian Style
Escudero-Sanchez, Rosa, Laura Morata, Luis Buzón, Sofia de la Villa, Alicia Rico, MarÃa José Nuñez Orantos, Laura Guio Carrion, MarÃa Tasias Pitarch, Jose Luis del Pozo, José M. Barbero,
and et al. 2025. "Dalbavancin as Suppressive Therapy for Implant-Associated Osteoarticular Infections" Antibiotics 14, no. 11: 1171.
https://doi.org/10.3390/antibiotics14111171
APA Style
Escudero-Sanchez, R., Morata, L., Buzón, L., de la Villa, S., Rico, A., Nuñez Orantos, M. J., Guio Carrion, L., Tasias Pitarch, M., del Pozo, J. L., Barbero, J. M., Gómez-Junyent, J., GarcÃa Pais, M. J., Bachiller Luque, P., MartÃnez Marcos, F. J., Cobo, J., & GEIO (Spanish Group for Osteoarticular Infections).
(2025). Dalbavancin as Suppressive Therapy for Implant-Associated Osteoarticular Infections. Antibiotics, 14(11), 1171.
https://doi.org/10.3390/antibiotics14111171
